177 related articles for article (PubMed ID: 22671773)
1. Protection of dopaminergic cells by urate requires its accumulation in astrocytes.
Cipriani S; Desjardins CA; Burdett TC; Xu Y; Xu K; Schwarzschild MA
J Neurochem; 2012 Oct; 123(1):172-81. PubMed ID: 22671773
[TBL] [Abstract][Full Text] [Related]
2. Protection by inosine in a cellular model of Parkinson's disease.
Cipriani S; Bakshi R; Schwarzschild MA
Neuroscience; 2014 Aug; 274():242-9. PubMed ID: 24880154
[TBL] [Abstract][Full Text] [Related]
3. Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.
Cipriani S; Desjardins CA; Burdett TC; Xu Y; Xu K; Schwarzschild MA
PLoS One; 2012; 7(5):e37331. PubMed ID: 22606360
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of astrocyte-derived 14,15-epoxyeicosatrienoic acid on hydrogen peroxide-induced cell injury in astrocyte-dopaminergic neuronal cell line co-culture.
Terashvili M; Sarkar P; Nostrand MV; Falck JR; Harder DR
Neuroscience; 2012 Oct; 223():68-76. PubMed ID: 22863680
[TBL] [Abstract][Full Text] [Related]
5. Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration.
Chen X; Burdett TC; Desjardins CA; Logan R; Cipriani S; Xu Y; Schwarzschild MA
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):300-5. PubMed ID: 23248282
[TBL] [Abstract][Full Text] [Related]
6. Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1
Bakshi R; Xu Y; Mueller KA; Chen X; Granucci E; Paganoni S; Sadri-Vakili G; Schwarzschild MA
Mol Cell Neurosci; 2018 Oct; 92():12-16. PubMed ID: 29928993
[TBL] [Abstract][Full Text] [Related]
7. Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease.
Kachroo A; Schwarzschild MA
Brain Res; 2014 May; 1563():103-9. PubMed ID: 24680743
[TBL] [Abstract][Full Text] [Related]
8. Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease.
Bao LH; Zhang YN; Zhang JN; Gu L; Yang HM; Huang YY; Xia N; Zhang H
J Neuroinflammation; 2018 May; 15(1):131. PubMed ID: 29720230
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release.
Bakshi R; Zhang H; Logan R; Joshi I; Xu Y; Chen X; Schwarzschild MA
Neurobiol Dis; 2015 Oct; 82():574-579. PubMed ID: 26341543
[TBL] [Abstract][Full Text] [Related]
10. Time- and activation-dependency of the protective effect of microglia on astrocytes exposed to peroxide-induced oxidative stress.
Armbrust E; Röhl C
Toxicol In Vitro; 2008 Aug; 22(5):1399-404. PubMed ID: 18367369
[TBL] [Abstract][Full Text] [Related]
11. Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes.
Douiri S; Bahdoudi S; Hamdi Y; Cubì R; Basille M; Fournier A; Vaudry H; Tonon MC; Amri M; Vaudry D; Masmoudi-Kouki O
J Neurochem; 2016 Jun; 137(6):913-30. PubMed ID: 26991551
[TBL] [Abstract][Full Text] [Related]
12. H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.
Fonseca CP; Gama S; Saavedra A; Baltazar G
Biochim Biophys Acta; 2014 Jul; 1842(7):927-34. PubMed ID: 24632468
[TBL] [Abstract][Full Text] [Related]
13. Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in Parkinsonian models.
Miyazaki I; Asanuma M; Murakami S; Takeshima M; Torigoe N; Kitamura Y; Miyoshi K
Neurobiol Dis; 2013 Nov; 59():244-56. PubMed ID: 23959140
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action.
Zhu TG; Wang XX; Luo WF; Zhang QL; Huang TT; Xu XS; Liu CF
Neurosci Lett; 2012 Jan; 506(2):175-9. PubMed ID: 22094380
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection.
Kikuoka R; Miyazaki I; Kubota N; Maeda M; Kagawa D; Moriyama M; Sato A; Murakami S; Kitamura Y; Sendo T; Asanuma M
Sci Rep; 2020 Nov; 10(1):20698. PubMed ID: 33244123
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems.
Bajo-Grañeras R; Ganfornina MD; Martín-Tejedor E; Sanchez D
Glia; 2011 Oct; 59(10):1551-66. PubMed ID: 21688324
[TBL] [Abstract][Full Text] [Related]
17. Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.
Zawada WM; Banninger GP; Thornton J; Marriott B; Cantu D; Rachubinski AL; Das M; Griffin WS; Jones SM
J Neuroinflammation; 2011 Oct; 8():129. PubMed ID: 21975039
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity.
Williamson TP; Johnson DA; Johnson JA
Neurotoxicology; 2012 Jun; 33(3):272-9. PubMed ID: 22342405
[TBL] [Abstract][Full Text] [Related]
19. Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?
De Luca MA; Cauli O; Morelli M; Simola N
J Neurochem; 2014 Nov; 131(3):284-9. PubMed ID: 24989117
[TBL] [Abstract][Full Text] [Related]
20. Neuroglobin protects astroglial cells from hydrogen peroxide-induced oxidative stress and apoptotic cell death.
Amri F; Ghouili I; Amri M; Carrier A; Masmoudi-Kouki O
J Neurochem; 2017 Jan; 140(1):151-169. PubMed ID: 27787886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]